JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene

Shruti P. Agnihotri, Xin Dang, Jonathan L. Carter, Terry D. Fife, Evelyn Bord, Stephanie Batson, Igor J. Koralnik

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint Dive into the research topics of 'JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene'. Together they form a unique fingerprint.

Medicine & Life Sciences